Join us at the CUA 2019 Annual Meeting happening on June 29 – July 1 in Quebec City to see the latest innovations in MRI-targeted prostate biopsy.
Our Fusion Bx prostate fusion biopsy platform is the only MRI-ultrasound fusion biopsy device that is designed, engineered and manufactured entirely here in Canada. With a semi-robotic arm that maintains the probe in any position, physicians are able to perform targeted biopsies with more accuracy and less effort. Moreover, the simple step-by-step guided user interface and short learning curve minimizes the impact on physician workload.
Stop by booth 606 for a demonstration of the Fusion Bx and to see why we are at the forefront of prostate cancer diagnosis.
We will also be participating in the MRI & Targeted Biopsy Hands-On Course on Monday, July 1 from 7-10 am. Here you will have the chance to see how our Fusion Bx provides an easy to learn and use method for performing MRI-targeted biopsies. Sign up today!